The innate immune system is a host defense mechanism that is evolutionarily conserved from insects to human and is mainly involved in the recognition and control of the early stage of infection in all animals (1). Over the last decade, it has become increasingly evident that also plants have acquired the ability to recognize "non self" via sensitive perception systems for components of microorganisms called pathogen-associated molecular patterns (PAMPs) 2 (2-4). As classically defined, PAMPs are highly characteristic of potentially infectious microbes, but are not present in the host. In addition, such patterns are often vital for microbial survival and are therefore not subject to mutational variation. PAMPs that trigger innate immune responses in various vertebrate and non-vertebrate organisms include lipopolysaccharides (LPS) from Gram-negative bacteria, eubacterial flagellin, viral, and bacterial nucleic acids, fungal cell wall-derived glucans, chitins, mannans, or proteins and peptidoglycans (PGN) from Gram-positive bacteria (5-8). Peptidoglycan (PGN) is an essential and unique component of the bacterial envelope that provides rigidity and structure to the bacterial cell. Virtually all bacteria contain a layer of PGN, but the amount, location, and specific composition vary. PGN is a polymer of alternating N-acetylglucosamine (GlcNAc) and N-acetyl-muramic acid (MurNAc) residues in ␤-1-4 linkage which are cross-linked by short peptides (9, 10). The glycan chains display little variation among different bacterial species while the peptide subunit and the interpeptide bridge reveal species specific differences. PGN from Staphylococcus aureus belongs to the L-lysine (Lys)-type, which is primarily found in Gram-positive bacteria whereas meso-diaminopimelate (Dap)-type PGN is typical for many Gram-negative bacteria.As PGNs are located on most bacterial surfaces they constitute excellent targets for recognition by the innate immune system. Indeed, PGN is known for a long time to promote an innate immune response in vertebrates and insects (11-13), and a breakdown product of PGN, muramyl dipeptide (MurNAc-L-Ala-D-Glu; MDP) was found to be the minimal chemical structure required for PAMP activity in mammals (14). PGN is perceived in animals via various pattern recognition receptors (PRRs), including scavenger receptors, nucleotide-binding oligomerization domain-containing proteins (NODs), a family of peptidoglycan recognition proteins (PGRPs), PGN-lytic enzymes and Toll-like receptor TLR2 (15-19).Remarkable similarities have been uncovered in the molecular mode of PAMP perception in animals and plants (2,20,21). Perception of flagellin in Arabidopsis was shown to be depend-* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Previously it has been demonstrated that Staphylococcus aureus is sensitive toward Pseudomonas-secreted exotoxins, which preferentially target the electron transport chain in staphylococci. Here it is shown that a subpopulation of S. aureus survives these respiratory toxins of Pseudomonas aeruginosa by selection of the small-colony variant (SCV) phenotype. Purified pyocyanin alone causes the same effect. A hemB mutant of S. aureus survives cocultivation with P. aeruginosa without a decrease in CFU.Pseudomonas aeruginosa and Staphylococcus aureus are opportunistic pathogens and frequently coinfect the lungs of patients with cystic fibrosis (CF). P. aeruginosa excretes an arsenal of small respiratory inhibitors, like pyocyanin (5), hydrogen cyanide (2), or quinoline N-oxides (9), that may act against the commensal microbiota as well as host cells. Previously it has been demonstrated that S. aureus is sensitive toward the toxic products generated by P. aeruginosa and that these exotoxins preferentially target the electron transport chain (17).Staphylococcal species can be divided into two groups: the sensitive group, comprising pathogenic species such as S. aureus and S. epidermidis, and the resistant group, represented by nonpathogenic species such as S. carnosus, S. piscifermentans, and S. gallinarum. The resistance in the latter group was due to cydAB genes, which encode a pyocyanin-and cyanide-resistant cytochrome bd quinol oxidase (17). It has also been shown that the resistant or sensitive phenotype is determined by the CydB subunit, which is part of the cytochrome bd quinol oxidase of S. aureus. Despite its sensitivity to these exotoxins, S. aureus has frequently been coisolated with P. aeruginosa from the skin, eyes, and catheter infections and from the lungs of patients with CF. The aim of this study is to elucidate the escape mechanism of S. aureus by cocultivating S. aureus and P. aeruginosa. The findings indicate that a subpopulation of the staphylococcal community can survive in the presence of P. aeruginosa by the selection of small-colony variants (SCVs), which usually are defective in the electron transport chain. SCVs grow as tiny, nonpigmented colonies and are auxotrophic to hemin, menadione, or thymidine (14). Here we show that both a culture supernatant of P. aeruginosa and purified pyocyanin select for the SCV phenotype in S. aureus.Cocultivation of S. aureus and P. aeruginosa can select for S. aureus SCVs. S. aureus was grown in monoculture or in coculture with P. aeruginosa (1:1, optical density at 578 nm) in tryptic soy broth (TSB) medium under biofilm or planktonic conditions. Biofilm studies using S. aureus(pCtuf-gfp) and P. aeruginosa::pUT-tell-rfp grown in TSB medium supplemented with 0.5% glucose under static conditions for 36 h showed that both S. aureus and P. aeruginosa form thicker biofilm in monocultures, while in a mixed biofilm with P. aeruginosa only few S. aureus cells were visible (Fig. 1A).Titers of S. aureus grown under planktonic conditions in monoculture and in coculture w...

The innate immune system constitutes the first line of defence against invading microbes. The basis of this defence resides in the recognition of defined structural motifs of the microbes called "Microbial associated molecular patterns" that are absent in the host. Cell wall, the outer layer of both bacterial and fungal cells, a unique structure that is absent in the host and is recognized by the germ line encoded host receptors. Nucleotide oligomerization domain proteins, peptidoglycan recognition proteins and C-type lectins are host receptors that are involved in the recognition of bacterial cell wall (usually called peptidoglycan), whereas fungal cell wall components (N- and O-linked mannans, β-glucans etc.) are recognized by host receptors like C-type lectins (Dectin-1, Dectin-2, mannose receptor, DC-SIGN), Toll like receptors-2 and -4 (TLR-2 and TLR-4). These recognitions lead to activation of a variety of host signaling cascades and ultimate production of anti-microbial compounds including phospholipase A2, antimicrobial peptides, lysozyme, reactive oxygen and nitrogen species. These molecules act in cohort against the invading microbes to eradicate infections. Additionally pathogen recognition leads to the production of cytokines, which further activate the adaptive immune system. Both pathogenic and commensal bacteria and fungus use numerous strategies to subvert the host defence. These strategies include bacterial peptidoglycan glycan backbone modifications by O-acetylation, N-deacetylation, N-glycolylation and stem peptide modifications by amidation of meso-Diaminopimelic acid; fungal cell wall modifications by shielding the β-glucan layer with mannoproteins and α-1,3 glucan. This review focuses on the recent advances in understanding the role of bacterial and fungal cell wall in their innate immune recognition and evasion strategies.

No abstract

Mediastinitis occurs after cardiac surgery and is a major threat to patient’s life due to postoperative bleeding and deep sternal wound infection. Major challenge in treating this condition is that it demands a material that should adhere to the applied site and act as both a hemostatic and an antibacterial agent. On the basis of this we have developed an in situ forming tissue adhesive chitin–fibrin (CH-FB) gel with tigecycline loaded gelatin nanoparticles (tGNPs) for controlling bleeding and preventing bacterial infection. Spherical shaped tGNPs (231 ± 20 nm) were prepared and characterized. In situ forming tGNPsCH-FB gel was formed using a dual syringe applicator in which one syringe was loaded with a mixer of fibrinogen solution, chitin gel, and tGNPs; the other syringe was loaded with a mixture of thrombin solution, chitin gel, and tGNPs. Both these mixtures were injected together. In situ gel formed within a minute and exhibited excellent tissue adhesive property. tGNPsCH-FB gel was found to be cyto-compatible against human umbilical vein endothelial cells (HUVECs). Sustained release of tigecycline from tGNPsCH-FB gel was found to occur over 21 days. In vitro antibacterial activity of tGNPsCH-FB gel was tested against Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli (E. coli), and their clinical isolates. Furthermore, in vivo hemostatic potential of tGNPsCH-FB gel was evaluated in deep organ injuries created in Sprague–Dawley rats. The developed gel exhibited rapid blood clotting potential by achieving hemostasis within 154 and 84 s under femoral artery (pressured) and liver (oozing) bleeding conditions. Hence, these findings exhibit the potential application of the developed tGNPsCH-FB gel to adhere at surgical site for controlling bleeding and prevent bacterial infection after cardiac surgery.